SELECT PUBLICATIONS

Escudier B et al; TARGET Study Group. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007;356(2):125-34. Abstract

Lacouture ME et al. Patterns of management of rash associated with epidermal
growth factor receptor inhibitors (EGFRIs): A national practice survey. Proc ASCO
2007;Abstract 14081.

Lacouture ME et al. The SERIES clinic: An interdisciplinary approach to the management
of toxicities of EGFR inhibitors. J Support Oncol 2006;4(5):236-8. No abstract available

Lynch TJ Jr et al. Epidermal growth factor receptor inhibitor-associated cutaneous
toxicities: An evolving paradigm in clinical management. Oncologist 2007;12(5):610-21. Abstract

Motzer RJ et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N
Engl J Med 2007;356(2):115-24. Abstract

Wagner L et al. Development of a functional assessment of side-effects to therapy (FAST)
questionnaire to assess dermatology-related quality of life in patients treated with
EGFR inhibitors (EGFRI): The FAST-EGFRI. Proc ASCO 2007;Abstract 19532.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Home

Editor
Neil Love, MD

Interviews

David I Quinn, MBBS, PhD
- Select publications

Walter Stadler, MD
- Select publications

Mario Lacouture, MD
- Select publications

Bernard J Escudier, MD
- Select publications

CME Information

Faculty Disclosures

Editor's Office